MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-26-0453303
Aumalfa Pharmaceutical Private Limited
Aumalfa Pharmaceutical Private Limited - pharma in Pune, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹37.13 Lakh
▲ 8% YoY
Net profit · FY 2024
₹42,153
Net margin 1.1%
EBITDA · FY 2024
₹54,043
EBITDA margin 1.5%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Aumalfa Pharmaceutical Private Limited
Data last updated:
Aumalfa Pharmaceutical Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 01 May 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U51909PN2017PTC170217. Its GSTIN is 27AAPCA5213K1ZH (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Lalit Mishrilal Bhandari and Neha Lalit Bhandari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Pune, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹37.13 Lakh, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹42,153 (net margin 1.1%) and EBITDA of ₹54,043 (EBITDA margin 1.5%). Revenue has grown at a compounded annual rate (CAGR) of 66% over five years.
Aumalfa Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0453303). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U51909PN2017PTC170217
Registration Number 170217
Incorporation Date 01 May 2017
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-26-0453303
Recognitions & Rankings of Aumalfa Pharmaceutical
Contact details
Aumalfa Pharmaceutical Private Limited's registered office is in Pune, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressOffice No. 504 5th Floor R K One Building H.No. 480/2 Off. Moledina Road Rasta Pe, Th, Pune, Maharashtra, India – 411011
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Aumalfa Pharmaceutical Private Limited, buy the company report.
Comprehensive company report
Aumalfa Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Aumalfa Pharmaceutical is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles |
To see the full business activity and turnover split of Aumalfa Pharmaceutical Private Limited, buy the company report.
Financials of Aumalfa Pharmaceutical Private Limited
FY 2025 filings availableAumalfa Pharmaceutical Private Limited reported revenue of ₹37.13 Lakh (up 8% YoY) for FY 2024.
Revenue · FY 2024
₹37.13 Lakh ▲ 8%
Net profit · FY 2024
₹42,153 margin 1.1%
EBITDA · FY 2024
₹54,043 margin 1.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 8%
5 years · compounded
▲ 66%
EBITDA CAGR growth
1 year
▼ 1%
3 years · compounded
▼ 29%
5 years · compounded
▲ 17%
Revenue has grown at a compounded annual rate (CAGR) of 66% over five years, including 8% growth in the latest year. EBITDA fell 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹54,043 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹42,153 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.5% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aumalfa Pharmaceutical Private Limited, buy the company report.
Board of directors of Aumalfa Pharmaceutical Private Limited
Aumalfa Pharmaceutical has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lalit Mishrilal Bhandari | Director | 01 May 2017 | 9 Years 5 Months | Current |
| Neha Lalit Bhandari | Director | 01 May 2017 | 9 Years 5 Months | Current |
Peer comparison
Aumalfa Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale and retail trade and repair of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nextgen Automotive Technology Private Limited | ₹37.36 Lakh (FY 2025) | Pune, Maharashtra, India | ||||
| Krishnaraj Staff Solutions Private Limited | ₹37.33 Lakh (FY 2025) | Lucknow, Uttar Pradesh, India | ||||
| Saarthak Flowtech Private Limited | ₹37.31 Lakh (FY 2025) | -56.0% | Rajkot, Gujarat, India | |||
| Sabwell Pharmaceuticals Private Limited | ₹37.27 Lakh (FY 2024) | Ahmedabad, Gujarat, India | ||||
| Kamleshwari Realtors & Developers Private Limited | ₹37.21 Lakh (FY 2025) | Lucknow, Uttar Pradesh, India | ||||
| Aumalfa Pharmaceutical Private Limitedthis company | ₹37.13 Lakh (FY 2024) | ₹42,153 | 1.1% | 8.0% | Pune, Maharashtra, India | |
| Seasaw Ventures Private Limited | ₹37.1 Lakh (FY 2024) | 2278.0% | Indore, Madhya Pradesh, India | |||
| Pace International Ltd. | ₹37.06 Lakh (FY 2025) | 181.0% | Mumbai, Maharashtra, India | |||
| Zinios Impex Private Limited | ₹36.88 Lakh (FY 2025) | 321.0% | Kolkata, West Bengal, India | |||
| Eco Medivent Equipments Private Limited | ₹36.81 Lakh (FY 2025) | -43.0% | Bengaluru, Karnataka, India | |||
| Sait Medicine Services Private Limited | ₹36.78 Lakh (FY 2024) | 346.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Aumalfa Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Aumalfa Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aumalfa Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aumalfa Pharmaceutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAPCA5213K1ZH | Maharashtra | Active | 29 Jan 2018 |
To see the full GST registrations and return filing status of Aumalfa Pharmaceutical Private Limited, buy the company report.
Recent activity
Aumalfa Pharmaceutical Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Lalit Mishrilal Bhandari was appointed as Director on 01 May 2017.
AGM
Aumalfa Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Aumalfa Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune.
Appointed
Lalit Mishrilal Bhandari was appointed as Director.
Appointed
Neha Lalit Bhandari was appointed as Director.
Incorporation
01 May 2017
Aumalfa Pharmaceutical Private Limited was registered on 01 May 2017 with Roc Pune & aged 9 years 5 months as per MCA records.
Frequently asked questions
Aumalfa Pharmaceutical is an active private limited company based in Pune, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 01 May 2017 (9+ years old) and is registered under CIN U51909PN2017PTC170217.
Aumalfa Pharmaceutical has 2 current directors:
- Lalit Mishrilal Bhandari - Director
- Neha Lalit Bhandari - Director
The latest financial statements of Aumalfa Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Aumalfa Pharmaceutical is 27AAPCA5213K1ZH, registered in Maharashtra.
The CIN (Corporate Identification Number) of Aumalfa Pharmaceutical is U51909PN2017PTC170217. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aumalfa Pharmaceutical was incorporated on 01 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Aumalfa Pharmaceutical by revenue are Nextgen Automotive Technology Private Limited, Krishnaraj Staff Solutions Private Limited, Saarthak Flowtech Private Limited, Sabwell Pharmaceuticals Private Limited, Kamleshwari Realtors & Developers Private Limited and 5 more, all in the same principal business activity (wholesale and retail trade and repair of motor vehicles and motorcycles).
Lalit Mishrilal Bhandari was appointed as Director on 01 May 2017. Neha Lalit Bhandari was appointed as Director on 01 May 2017.
Yes, Aumalfa Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-26-0453303).
The registered office of Aumalfa Pharmaceutical is at Office No. 504 5th Floor R K One Building H.No. 4802 Off. Moledina Road Rasta Pe, Th, Pune, Maharashtra, India – 411011.
Aumalfa Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.